Hims & Hers Health (HIMS) News Today $49.10 -17.32 (-26.07%) Closing price 03:59 PM EasternExtended Trading$48.72 -0.38 (-0.77%) As of 05:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Why Hims & Hers Health Stock Is Plummeting TodayFebruary 21 at 2:37 PM | fool.comHims & Hers Stock Plummets. The Wegovy Shortage Is Over.February 21 at 1:19 PM | barrons.comShares of Hims & Hers tumble 23% after FDA says semaglutide is no longer in shortageFebruary 21 at 12:56 PM | cnbc.comHims & Hers (HIMS) Down 21% – Is the GLP-1 Gravy Train Over?February 21 at 12:07 PM | 247wallst.comHims & Hers (HIMS) Down 21% – Is the GLP-1 Gravy Train Over?February 21 at 11:47 AM | 247wallst.comHims & Hers Health (NYSE:HIMS) Trading Down 17.6% Following Insider SellingHims & Hers Health (NYSE:HIMS) Trading Down 17.6% After Insider SellingFebruary 21 at 11:22 AM | marketbeat.comHims Stock Crashes After FDA Resolves Weight-Loss Drugs ShortageFebruary 21 at 11:05 AM | investors.comHims & Hers Health (NYSE:HIMS) Sees Strong Trading Volume on Analyst UpgradeHims & Hers Health (NYSE:HIMS) Sees Large Volume Increase Following Analyst UpgradeFebruary 21 at 10:31 AM | marketbeat.comHims & Hers Health, Inc. (NYSE:HIMS) Insider Soleil Boughton Sells 4,152 SharesFebruary 21 at 6:48 AM | insidertrades.comBank of America Forecasts Strong Price Appreciation for Hims & Hers Health (NYSE:HIMS) StockBank of America raised their price objective on Hims & Hers Health from $18.00 to $21.00 and gave the company an "underperform" rating in a research report on Thursday.February 21 at 5:51 AM | marketbeat.comHims & Hers Health (NYSE:HIMS) Reaches New 1-Year High After Analyst UpgradeFebruary 21 at 1:13 AM | americanbankingnews.comHims & Hers: After A 205% Gain, Downgrading To A Hold, But Options Present An OpportunityFebruary 20 at 10:53 PM | seekingalpha.comHims & Hers Health, Inc. (NYSE:HIMS) Insider Soleil Boughton Sells 4,152 SharesHims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) insider Soleil Boughton sold 4,152 shares of Hims & Hers Health stock in a transaction that occurred on Tuesday, February 18th. The shares were sold at an average price of $60.69, for a total transaction of $251,984.88. Following the completion of the sale, the insider now owns 157,345 shares of the company's stock, valued at approximately $9,549,268.05. The trade was a 2.57 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.February 20 at 8:39 PM | marketbeat.comHims & Hers Health, Inc. (NYSE:HIMS) CEO Andrew Dudum Sells 128,127 SharesHims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) CEO Andrew Dudum sold 128,127 shares of the business's stock in a transaction dated Tuesday, February 18th. The shares were sold at an average price of $58.27, for a total value of $7,465,960.29. Following the completion of the transaction, the chief executive officer now directly owns 97,687 shares in the company, valued at $5,692,221.49. This represents a 56.74 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.February 20 at 8:35 PM | marketbeat.comHims & Hers Health (NYSE:HIMS) Trading Down 5.9% - Here's WhyHims & Hers Health (NYSE:HIMS) Trading Down 5.9% - Should You Sell?February 20 at 8:31 PM | marketbeat.comMarket Whales and Their Recent Bets on HIMS OptionsFebruary 20 at 6:20 PM | benzinga.comHims & Hers Health: The Ultimate Pick For The Next DecadeFebruary 20 at 3:10 PM | seekingalpha.comWhy Hims & Hers Stock Dropped TodayFebruary 20 at 2:25 PM | fool.comHims & Hers Health (NYSE:HIMS) Shares Gap Down - Here's WhyHims & Hers Health (NYSE:HIMS) Shares Gap Down - Here's What HappenedFebruary 20 at 12:12 PM | marketbeat.comCanaccord Genuity Group Increases Hims & Hers Health (NYSE:HIMS) Price Target to $68.00Canaccord Genuity Group raised their target price on Hims & Hers Health from $38.00 to $68.00 and gave the stock a "buy" rating in a research report on Wednesday.February 20 at 10:37 AM | marketbeat.comHims & Hers price target raised to $21 from $18 at BofAFebruary 20 at 8:18 AM | markets.businessinsider.comHims & Hers Health (NYSE:HIMS) Given New $21.00 Price Target at Bank of AmericaBank of America raised their price objective on shares of Hims & Hers Health from $18.00 to $21.00 and gave the company an "underperform" rating in a research note on Thursday.February 20 at 8:02 AM | marketbeat.comConvergence Investment Partners LLC Takes $381,000 Position in Hims & Hers Health, Inc. (NYSE:HIMS)Convergence Investment Partners LLC purchased a new stake in Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 15,762 shares of the company's stock, vFebruary 20 at 4:45 AM | marketbeat.comHims & Hers: The Pros And Cons Of The Trybe AcquisitionFebruary 20 at 3:17 AM | seekingalpha.comHims & Hers Health Shares Hit All-Time High After Testing Facility BuyFebruary 20 at 3:17 AM | marketwatch.comHims and Hers Health call volume above normal and directionally bullishFebruary 20 at 3:17 AM | markets.businessinsider.comHims & Hers Health surges on acquisition for at-home testingFebruary 20 at 3:17 AM | finance.yahoo.comHims & Hers Health (NYSE:HIMS) Cut to Equal Weight at Morgan StanleyFebruary 20 at 2:31 AM | americanbankingnews.comHims & Hers Health (NYSE:HIMS) Sets New 52-Week High After Analyst UpgradeHims & Hers Health (NYSE:HIMS) Reaches New 1-Year High After Analyst UpgradeFebruary 20 at 1:38 AM | marketbeat.comHims & Hers Health (NYSE:HIMS) Shares Down 5.9% - Here's WhyHims & Hers Health (NYSE:HIMS) Trading Down 5.9% - Here's WhyFebruary 19 at 10:35 PM | marketbeat.comHims & Hers Stock Hits Record High on Blood-Testing Lab AcquisitionFebruary 19 at 3:30 PM | investopedia.comWhy Hims & Hers Health Stock Is Skyrocketing TodayFebruary 19 at 2:14 PM | fool.comMedical Stocks To Consider - February 19thHims & Hers Health, Eli Lilly and Company, Tempus AI, UnitedHealth Group, Walmart, Merck & Co., Inc., and Johnson & Johnson are the seven Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks refer to publicly traded companies that operate within the healthcarFebruary 19 at 2:11 PM | marketbeat.comHealthcare Stocks To Keep An Eye On - February 19thHims & Hers Health, Alphabet, and Analog Devices are the three Healthcare stocks to watch today, according to MarketBeat's stock screener tool. Healthcare stocks refer to publicly traded companies in the healthcare industry that provide products or services related to healthcare. These stocks can iFebruary 19 at 2:11 PM | marketbeat.comHims & Hers Health (NYSE:HIMS) Hits New 1-Year High on Analyst UpgradeHims & Hers Health (NYSE:HIMS) Hits New 52-Week High on Analyst UpgradeFebruary 19 at 11:32 AM | marketbeat.comHims & Hers Health stock soars on Trybe Labs acquisitionFebruary 19 at 10:48 AM | au.investing.comHims & Hers Health stock soars on Trybe Labs acquisitionFebruary 19 at 10:48 AM | au.investing.comHims & Hers price target raised to $68 from $38 at CanaccordFebruary 19 at 10:48 AM | markets.businessinsider.comHims & Hers price target raised to $68 from $38 at CanaccordFebruary 19 at 10:48 AM | markets.businessinsider.comHims & Hers acquires at-home lab testing facility, terms undisclosedFebruary 19 at 10:48 AM | markets.businessinsider.comHims & Hers acquires at-home lab testing facility, terms undisclosedFebruary 19 at 10:48 AM | markets.businessinsider.comHims & Hers Buys Lab to Expand Into At-Home Blood TestingFebruary 19 at 10:48 AM | msn.comHims & Hers Buys Lab to Expand Into At-Home Blood TestingFebruary 19 at 10:48 AM | msn.comHims & Hers to offer at-home blood draws and lab testing with new acquisitionFebruary 19 at 9:32 AM | cnbc.comHims & Hers Acquires At-Home Lab Testing Facility, Expanding Capabilities to Ultimately Include Affordable Whole Body Testing for SubscribersFebruary 19 at 9:00 AM | businesswire.comHims & Hers Health (NYSE:HIMS) Downgraded to Equal Weight Rating by Morgan StanleyMorgan Stanley downgraded Hims & Hers Health from an "overweight" rating to an "equal weight" rating and boosted their price objective for the company from $42.00 to $60.00 in a research note on Tuesday.February 19 at 7:40 AM | marketbeat.comHims & Hers Q4 Preview: Is The Super Bowl Ad Worth $5B In Market Cap? (Rating Downgrade)February 18 at 10:03 PM | seekingalpha.comMorgan Stanley Downgrades Hims & Hers Health (HIMS)February 18 at 4:53 PM | msn.comHims & Hers Earnings Could Be a Game Changer—What to Do NowAfter a massive 500% run over the past 12 months, shares of Hims & Hers stock might have another trick saved up before earnings announcements.February 18 at 2:02 PM | marketbeat.com3 Hot Stocks That Have Already Doubled in 2025February 18 at 11:50 AM | fool.com Get Hims & Hers Health News Delivered to You Automatically Sign up to receive the latest news and ratings for HIMS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Videos HIMS Media Mentions By Week HIMS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HIMS News Sentiment▼0.420.60▲Average Medical News Sentiment HIMS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HIMS Articles This Week▼7317▲HIMS Articles Average Week Get Hims & Hers Health News Delivered to You Automatically Sign up to receive the latest news and ratings for HIMS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NTRA News Today FMS News Today GH News Today OPCH News Today RDNT News Today BTSG News Today SHC News Today SGRY News Today VCYT News Today LFST News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:HIMS) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hims & Hers Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hims & Hers Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HIMS Stock Alerts